NEOVACS Trademark

Trademark Overview

On Tuesday, August 29, 1995, a trademark application was filed for NEOVACS with the United States Patent and Trademark Office. The USPTO has given the NEOVACS trademark a serial number of 74722439. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, October 24, 2017. This trademark is owned by NEOVACS. The NEOVACS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, medicine or vaccines used for the treatment of viral or auto-immune diseases or related to cytokini disorders used by humans
neovacs

General Information

Serial Number74722439
Word MarkNEOVACS
Filing DateTuesday, August 29, 1995
Status800 - REGISTERED AND RENEWED
Status DateTuesday, October 24, 2017
Registration Number2094111
Registration DateTuesday, September 9, 1997
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 25, 1997

Trademark Statements

Goods and Servicespharmaceutical preparations, namely, medicine or vaccines used for the treatment of viral or auto-immune diseases or related to cytokini disorders used by humans

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 22, 1995
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNEOVACS
Party Type30 - Original Registrant
Legal Entity Type99 - Other
Address75014 PARIS
FR
Party NameNEOVACS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address75014 Paris
FR
Party NameNEOVACS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address75014Paris
FR

Trademark Events

Event DateEvent Description
Tuesday, October 24, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, October 24, 2017REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Tuesday, October 24, 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, October 24, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 28, 2017TEAS SECTION 8 & 9 RECEIVED
Thursday, September 28, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 27, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 27, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 9, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, February 5, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 5, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 14, 2016REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY NOT ENTERED
Wednesday, January 13, 2016TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, October 12, 2007REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, October 12, 2007REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, September 19, 2007ASSIGNED TO PARALEGAL
Friday, September 7, 2007REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Friday, September 7, 2007TEAS SECTION 8 & 9 RECEIVED
Friday, March 2, 2007CASE FILE IN TICRS
Wednesday, January 28, 2004REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, November 17, 2003REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, September 9, 1997REGISTERED-PRINCIPAL REGISTER
Thursday, March 20, 1997EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 25, 1997PUBLISHED FOR OPPOSITION
Friday, January 24, 1997NOTICE OF PUBLICATION
Wednesday, September 11, 1996APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 5, 1996CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 29, 1996NON-FINAL ACTION MAILED
Thursday, February 15, 1996ASSIGNED TO EXAMINER

Related Keywords

neovacs used diseases immune related cytokini humans disorders auto viral namely